GLI1 and cancer: Direct comparison between KIRC tumor tissues and morphologically unchanged (control) kidney samples revealed a lack of statistical difference between the expression of SHH (Fig. 3A) and approximately 1.25- and 1.5 higher immunoreactivity of GLI1 and VEGFA proteins, respectively, in cancer cells (Fig. 3B,C).